Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 201 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolic Regulation Clear all

Conditions: Obesity, Prediabetes
Interventions: Mirabegron; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Obesity, Eating Disorders
Interventions: Appetite Awareness, Nutrition Education; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 20 Years · Female only
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Obesity
Interventions: Water, Sucralose; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years to 40 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pediatric Obesity, Executive Function
Interventions: Web Based Treatment; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 8 Years to 14 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Diabetes Mellitus, Type 1, Hypoglycemia Unawareness
Interventions: Dichloroacetate; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Aging, Inflammaging, Metabolic Health, Quercetin, Coenzyme Q10
Interventions: Quercetin (dietary supplement), Coenzyme Q10, Rice Flour; Dietary Supplement
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Obesity, Gastric Emptying, Anxiety, Depression, Panic Disorder
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity
Interventions: overfeeding, growth hormone treatment; Other · Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 35 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Metabolic Side Effects of Drugs
Interventions: SULT Allosteric Inhibition; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 61 Years to 61 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Overweight and Obesity
Interventions: Behavioral Weight Loss (BWL) + Emotion Regulation (ER), Behavioral Weight Loss (BWL); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 13 Years to 16 Years
Enrollment: 332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: La Jolla, California • Minneapolis, Minnesota

Conditions: Dehydration, Diabetes Mellitus, Type 2
Interventions: Water Intake; Other
Lead sponsor: Arizona State University; Other
Eligibility: 30 Years to 55 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Healthy, Heart Disease
Interventions: No intervention, observational study; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 6 Years and older
Enrollment: 325 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Mather, California

Conditions: Insulin Resistance
Interventions: Placebo, Resveratrol; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Type 2 Diabetes
Interventions: Rosiglitazone, Glyburide; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years to 75 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Toledo, Ohio

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Not listed
Lead sponsor: University of Arizona; Other
Eligibility: 21 Years to 65 Years
Enrollment: 72 participants
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Hypertriglyceridemia
Interventions: Not listed
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 1996 – 2000
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Diabetes Mellitus, Type 1
Interventions: high GI meal, low GI meal, euglycemic insulin clamp, primed-variable insulin infusion; Other · Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insulin Sensitivity, Multiple Mitochondrial Dysfunctions Syndrome
Interventions: Dapagliflozin, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetes Mellitus, Type 1
Interventions: Blood Glucose Awareness Training for Parents; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 6 Years to 11 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: Boston, Massachusetts • Charlottesville, Virginia

Conditions: Obesity, Depression
Interventions: I-CARE2; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Branched-chain Amino Acid Metabolism, Insulin Sensitivity
Interventions: Pre-Diabetes Group - 6-mo Aerobic and Resistance combined exercise training, GBP Group - Non-diabetics intending to undergo Gastric Bypass surgery; Other
Lead sponsor: Duke University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Type 2 Diabetes, Obesity
Interventions: DvtProgram ENERGY, DvtProgramENERGY; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 6 Years to 13 Years
Enrollment: 1,703 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2008
U.S. locations: 2
States / cities: Cortez, Colorado • Fort Collins, Colorado

Conditions: Obesity, Insulin Resistance
Interventions: placebo, pioglitazone; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Overweight and Obesity, Physical Activity, Weight Change, Body, Eating Behavior
Interventions: Intervention group, Control group; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: University Park, Pennsylvania

Search by objective public record fields.

ADRB3 Signaling Pathway in Human Adipose Tissue

A Brief Appetite Awareness Intervention for Eating and Weight Regulation Among College Freshmen

Sugar-replacement Sweeteners, and Blood Sugar Control

Virtual Health Focused Acceptance-Based Program for Parents and Youth

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

Growth Hormone as a Determinant of Weight Regulation

Studies of Sulfur Metabolism in Humans

FRESH-TEEN: Families Responsibility Education Support Health for Teens

INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers

Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups

Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome

Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes

MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3)

Regulation of Sterol Homeostasis

Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

Blood Glucose Awareness Training for Parents

Engaging Self-regulation Targets to Improve Mood and Weight and Understand Mechanism in Depressed and Obese Adults

Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes

Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment

Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin

Healthy Mom Zone: A Gestational Weight Gain Management Intervention